artrix, Author at Vivo Capital | Healthcare Focused Investment Firm - Page 2 of 4

About artrix

This author has not yet filled in any details.
So far artrix has created 36 blog entries.

RemeGen Completes USD $100 Million Plus in Funding
Gallery
RemeGen Completes USD $100 Million Plus in Funding

All News, Portfolio News

RemeGen Completes USD $100 Million Plus in Funding

RemeGen Completes USD $100 Million Plus in Fundingartrix2020-04-21T13:04:42-07:00

Gilead to Acquire Forty Seven for $4.9 Billion
Gallery
Gilead to Acquire Forty Seven for $4.9 Billion

All News, Portfolio News

Gilead to Acquire Forty Seven for $4.9 Billion

Gilead to Acquire Forty Seven for $4.9 Billionartrix2020-06-18T17:04:46-07:00

Passage Bio Announces Pricing of Initial Public Offering
Gallery
Passage Bio Announces Pricing of Initial Public Offering

All News, Portfolio News

Passage Bio Announces Pricing of Initial Public Offering

Passage Bio Announces Pricing of Initial Public Offeringartrix2020-06-18T17:01:08-07:00

Revolution Medicines Announces Pricing of Initial Public Offering
Gallery
Revolution Medicines Announces Pricing of Initial Public Offering

All News, Portfolio News

Revolution Medicines Announces Pricing of Initial Public Offering

Revolution Medicines Announces Pricing of Initial Public Offeringartrix2020-06-18T17:03:04-07:00

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Gallery
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

All News, Portfolio News

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumorsartrix2019-11-13T04:26:51-08:00

Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants
Gallery
Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants

All News, Portfolio News

Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants

Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrantsartrix2020-06-20T10:45:51-07:00

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies
Gallery
Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

All News, Vivo News

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companies

Vivo Capital Closes $1.43 Billion Fund IX to [...]

Vivo Capital Closes $1.43 Billion Fund IX to Invest in Healthcare and Life Science Companiesartrix2019-10-30T13:46:20-07:00

12 VCs who matter in biotech, but you never read about
Gallery
12 VCs who matter in biotech, but you never read about

All News, Vivo News

12 VCs who matter in biotech, but you never read about

12 VCs who matter in biotech, but [...]

12 VCs who matter in biotech, but you never read aboutartrix2019-11-05T22:24:30-08:00

Swift Health Systems Raises $45 Million in Series C Funding
Gallery
Swift Health Systems Raises $45 Million in Series C Funding

All News, Vivo News

Swift Health Systems Raises $45 Million in Series C Funding

Swift Health Systems Raises $45 Million in [...]

Swift Health Systems Raises $45 Million in Series C Fundingartrix2020-01-22T00:27:56-08:00

IGM Biosciences Announces Pricing of Initial Public Offering
Gallery
IGM Biosciences Announces Pricing of Initial Public Offering

All News, Portfolio News

IGM Biosciences Announces Pricing of Initial Public Offering

IGM Biosciences Announces Pricing of Initial Public Offeringartrix2020-06-18T16:58:47-07:00

Previous 123 Next